nnpNeurology, Neuropsychiatry, PsychosomaticsНеврология, нейропсихиатрия, психосоматика2074-27112310-1342"IMA-Press", LLC10.14412/2074-2711-2022-1-4-13nnp-1741Research ArticleCLINICAL GUIDELINESКЛИНИЧЕСКИЕ РЕКОМЕНДАЦИИEvaluation and treatment of medication-overuse headache: Russian experts’ guidelinesДиагностика и лечение лекарственно-индуцированной головной боли: рекомендации российских экспертовhttps://orcid.org/0000-0002-3833-532XТабееваГ. Р.TabeevaG. R.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

grtabeeva@gmail.comhttps://orcid.org/0000-0002-1570-5009ОсиповаВ. В.OsipovaV. V.

115419, Москва, ул. Донская, 43

43, Donskaya St., Moscow 115419

https://orcid.org/0000-0001-9978-4180ФилатоваЕ. Г.FilatovaE. G.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0002-3713-4884АзимоваЮ. Э.AzimovaYu. E.

121467, Москва, ул. Молодогвардейская, 2, корп. 1; 

125315, Москва, ул. Балтийская, 8

2, Molodogvardeiskaya St., Build. 1, Moscow 121467;

8, Baltiyskaya St., Moscow 125315

https://orcid.org/0000-0001-6437-232XАмелинА. В.AmelinA. V.

197022, Санкт-Петербург, ул. Льва Толстого, 6-8

6–8, Lev Tolstoy St., Saint Petersburg 197022

https://orcid.org/0000-0002-6219-3384АртеменкоА. Р.ArtyomenkoA. R.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0001-9250-8220ВоробьеваЮ. Д.VorobyevaYu. D.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0002-3638-6094ЕкушеваЕ. В.EkushevaE. V.

125371, Москва, Волоколамское ш., 91;

308015, Белгород, ул. Победы, 85; 

125130, Москва, Старопетровский проезд, 10Б;

127006, Москва, ул. Фадеева, 4а, стр. 1

91, Volokolamskoe Shosse, Moscow 125371;

85, Pobedy St., Belgorod 308015;

10B, Staropetrovskiy proezd, Moscow 125130;4a, Fadeeva St., Build. 1, Moscow 127006

https://orcid.org/0000-0002-4908-1193КорешкинаМ. И.KoreshkinaM. I.

197046, Санкт-Петербург, ул. Мичуринская, 1

1, Michurinskaya St., Saint Petersburg 197046

https://orcid.org/0000-0003-2463-7113ЛебедеваЕ. Р.LebedevaE. R.

620028, Екатеринбург, ул. Репина, 3;

620144, Екатеринбург, ул. Фурманова, 67

3, Repin St., Yekaterinburg 620028;

67, Furmanova St., Yekaterinburg 620144

https://orcid.org/0000-0001-9600-5540ЛатышеваН. В.LatyshevaN. V.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0003-4204-2279НаприенкоМ. В.NaprienkoM. V.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0002-7142-3719СергеевА. В.SergeevA. V.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0002-1279-9548СкоробогатыхК. В.SkorobogatykhK. V.

121467, Москва, ул. Молодогвардейская, 2, корп. 1; 

2, Molodogvardeiskaya St., Build. 1, Moscow 121467

https://orcid.org/0000-0002-2752-4109ГоловачеваВ. А.GolovachevaV. A.

8, Trubetskaya St., Build. 2, Moscow 119991

https://orcid.org/0000-0003-4266-0050РачинА. П.RachinA. P.

121099, Москва, ул. Новый Арбат, 32

32, Novyi Arbat St., Moscow 121099

https://orcid.org/0000-0002-1992-7960ПарфеновВ. А.ParfenovV. A.

119991, Москва, ул. Трубецкая, 8, стр. 2

8, Trubetskaya St., Build. 2, Moscow 119991

ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)РоссияI.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of RussiaRussian FederationГБУЗ «Научно-практический психоневрологический центр им. З.П. Соловьева Департамента здравоохранения города Москвы»РоссияResearch and Practical Psychoneurology Center, Moscow Healthcare DepartmentRussian FederationООО «Университетская клиника головной боли»; ФГБНУ «Научно-исследовательский институт общей патологии и патофизиологии»РоссияOOO «University Headache Clinic»; Research Institute of General Pathology and PathophysiologyRussian FederationФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. И.П. Павлова» Минздрава РоссииРоссияI.P. Pavlov First Saint Petersburg State Medical University, Ministry of Health of RussiaRussian FederationАкадемия постдипломного образования ФГБУ «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий ФМБА»; ФГАОУ ВО «Белгородский государственный национальный исследовательский университет»; Клиника головной боли и вегетативных расстройств им. академика А. Вейна; ООО «ГУТА КЛИНИК»РоссияAcademy of Postgraduate Education, Federal Scientific and Clinical Center for Specialized Types of Medical Aid and Medical Technologies, FMBA of Russia; Belgorod State National Research University; Acad. A. Vein Clinic of Headache and Autonomic Disorders; OOO “GUTA CLINIC”Russian FederationКлиника «Медицинская коллегия»РоссияClinic “Medical Board”Russian FederationФГБОУ ВО «Уральский государственный медицинский университет» Минздрава России; Международный центр лечения головной боли «Европа-Азия»РоссияUral State Medical University, Ministry of Health of Russia; International Headache Treatment Center “Europe-Asia”Russian FederationООО «Университетская клиника головной боли»РоссияOOO «University Headache Clinic»Russian FederationФГБУ «Национальный медицинский исследовательский центр реабилитации и курортологии» Минздрава РоссииРоссияNational Medical Research Center for Rehabilitation and Balneology, Ministry of Health of RussiaRussian Federation202222022022141413Copyright © Tabeeva G.R., Osipova V.V., Filatova E.G., Azimova Y.E., Amelin A.V., Artyomenko A.R., Vorobyeva Y.D., Ekusheva E.V., Koreshkina M.I., Lebedeva E.R., Latysheva N.V., Naprienko M.V., Sergeev A.V., Skorobogatykh K.V., Golovacheva V.A., Rachin A.P., Parfenov V.A., 20222022Табеева Г.Р., Осипова В.В., Филатова Е.Г., Азимова Ю.Э., Амелин А.В., Артеменко А.Р., Воробьева Ю.Д., Екушева Е.В., Корешкина М.И., Лебедева Е.Р., Латышева Н.В., Наприенко М.В., Сергеев А.В., Скоробогатых К.В., Головачева В.А., Рачин А.П., Парфенов В.А.Tabeeva G.R., Osipova V.V., Filatova E.G., Azimova Y.E., Amelin A.V., Artyomenko A.R., Vorobyeva Y.D., Ekusheva E.V., Koreshkina M.I., Lebedeva E.R., Latysheva N.V., Naprienko M.V., Sergeev A.V., Skorobogatykh K.V., Golovacheva V.A., Rachin A.P., Parfenov V.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://nnp.ima-press.net/nnp/article/view/1741

The Russian experts’ guidelines on evaluation and treatment of medication-overuse headache are based on evidence-based medicine, the latest revision of the International Classification of Headache Disorders. Basic information about epidemiology, risk factors, pathophysiological mechanisms, evaluation, and the most effective pharmacological drug and non-pharmacological approaches to managing patients with medication-overuse headache are presented. 

Рекомендации российских экспертов по диагностике и лечению лекарственно-индуцированной головной боли составлены на основании доказательной медицины, Международной классификации головных болей последнего пересмотра. Изложены основные сведения об эпидемиологии, факторах риска, патофизиологических механизмах, диагностике и наиболее эффективных лекарственных и немедикаментозных подходах к ведению пациентов с лекарственно-индуцированной головной болью. 

лекарственно-индуцированная головная больдиагностикаклассификацияхроническая мигреньхроническая головная боль напряжениялечение лекарственно-индуцированной головной болипрофилактиканелекарственные методыmedication-overuse headacheevaluationclassificationchronic migrainechronic tension-type headachemedication-overuse headache treatmentpreventionnon-pharmacological methodsReferencesDiener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016 Oct;12(10):575-83. doi: 10.1038/nrneurol.2016.124. Epub 2016 Sep 12.Diener HC, Holle D, Solbach K, Gaul C. Medication-overuse headache: risk factors, pathophysiology and management. Nat Rev Neurol. 2016 Oct;12(10):575-83. doi: 10.1038/nrneurol.2016.124. Epub 2016 Sep 12.Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medicationoveruse headache. Lancet Neurol. 2010 Apr;9(4):391-401. doi: 10.1016/S1474-4422(10)70008-9Evers S, Marziniak M. Clinical features, pathophysiology, and treatment of medicationoveruse headache. Lancet Neurol. 2010 Apr;9(4):391-401. doi: 10.1016/S1474-4422(10)70008-9Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders ICHD-3, 3rd edition. Cephalalgia. 2018 Jan;38(1):1-211. doi: 10.1177/0333102417738202Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-25. doi: 10.1177/0333102413512033Westergaard ML, Hansen EH, Glümer C, et al. Definitions of medication-overuse headache in population-based studies and their implications on prevalence estimates: a systematic review. Cephalalgia. 2014;34(6):409-25. doi: 10.1177/0333102413512033Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-yearold persons. The Akershus study of chronic headache. Cephalalgia. 2008 Jul;28(7):705-13. doi: 10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.Aaseth K, Grande RB, Kvaerner KJ, et al. Prevalence of secondary chronic headaches in a population-based sample of 30–44-yearold persons. The Akershus study of chronic headache. Cephalalgia. 2008 Jul;28(7):705-13. doi: 10.1111/j.1468-2982.2008.01577.x. Epub 2008 May 21.Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi: 10.1177/0333102411410082. Epub 2011 May 31.Jonsson P, Hedenrud T, Linde M. Epidemiology of medication overuse headache in the general Swedish population. Cephalalgia. 2011 Jul;31(9):1015-22. doi: 10.1177/0333102411410082. Epub 2011 May 31.Straube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2010 Feb;30(2):207-13. doi: 10.1111/j.1468-2982.2009.01906.xStraube A, Pfaffenrath V, Ladwig KH, et al. Prevalence of chronic migraine and medication overuse headache in Germany – the German DMKG headache study. Cephalalgia. 2010 Feb;30(2):207-13. doi: 10.1111/j.1468-2982.2009.01906.xAyzenberg I, Katsarava Z, Sborowski A, et al; Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012 Apr;32(5):373-81. doi: 10.1177/0333102412438977Ayzenberg I, Katsarava Z, Sborowski A, et al; Lifting the Burden. The prevalence of primary headache disorders in Russia: a countrywide survey. Cephalalgia. 2012 Apr;32(5):373-81. doi: 10.1177/0333102412438977Vandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018 Jul 13;19(1):50. doi: 10.1186/s10194-018-0875-xVandenbussche N, Laterza D, Lisicki M, et al. Medication-overuse headache: a widely recognized entity amidst ongoing debate. J Headache Pain. 2018 Jul 13;19(1):50. doi: 10.1186/s10194-018-0875-xDyb G, Holmen T, Zwart J. Analgesic overuse among adolescents with headache: The HeadHunt-Youth Study. Neurology. 2006 Jan 24;66(2):198-201. doi: 10.1212/01.wnl.0000193630.03650.19Dyb G, Holmen T, Zwart J. Analgesic overuse among adolescents with headache: The HeadHunt-Youth Study. Neurology. 2006 Jan 24;66(2):198-201. doi: 10.1212/01.wnl.0000193630.03650.19Lipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011 May;51(5):693-706. doi: 10.1111/j.1526-4610.2011.01885.xLipton RB, Manack A, Ricci JA, et al. Prevalence and burden of chronic migraine in adolescents: results of the chronic daily headache in adolescents study (C-dAS). Headache. 2011 May;51(5):693-706. doi: 10.1111/j.1526-4610.2011.01885.xWiendels NJ, van der Geest MC, Neven AK, et al. Chronic daily headache in children and adolescents. Headache. 2005 Jun;45(6):678-83. doi: 10.1111/j.1526-4610.2005.05137.xWiendels NJ, van der Geest MC, Neven AK, et al. Chronic daily headache in children and adolescents. Headache. 2005 Jun;45(6):678-83. doi: 10.1111/j.1526-4610.2005.05137.xDe Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018 Apr;58(4):525-33. doi: 10.1111/head.13247. Epub 2017 Dec 13.De Rijk P, Resseguier N, Donnet A. Headache characteristics and clinical features of elderly migraine patients. Headache. 2018 Apr;58(4):525-33. doi: 10.1111/head.13247. Epub 2017 Dec 13.Diener HC, Limmroth V. Medication-overused headache: a worldwide problem. Lancet Neurol. 2004 Aug;3(8):475-83. doi: 10.1016/S1474-4422(04)00824-5Diener HC, Limmroth V. Medication-overused headache: a worldwide problem. Lancet Neurol. 2004 Aug;3(8):475-83. doi: 10.1016/S1474-4422(04)00824-5Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004 Apr 27;62(8):1338-42. doi: 10.1212/01.wnl.0000120545.45443.93Colas R, Munoz P, Temprano R, et al. Chronic daily headache with analgesic overuse: epidemiology and impact on quality of life. Neurology. 2004 Apr 27;62(8):1338-42. doi: 10.1212/01.wnl.0000120545.45443.93Meskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006 May;46(5):766-72. doi: 10.1111/j.1526-4610.2006.00442.xMeskunas CA, Tepper SJ, Rapoport AM, et al. Medications associated with probable medication overuse headache reported in a tertiary care headache center over a 15-year period. Headache. 2006 May;46(5):766-72. doi: 10.1111/j.1526-4610.2006.00442.xFind NL, Terlizzi R, Munksgaard SB, et al; COMOESTAS Consortium. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. doi: 10.1186/s10194-016-0612-2. Epub 2016 Mar 8.Find NL, Terlizzi R, Munksgaard SB, et al; COMOESTAS Consortium. Medication overuse headache in Europe and Latin America: general demographic and clinical characteristics, referral pathways and national distribution of painkillers in a descriptive, multinational, multicenter study. J Headache Pain. 2015;17:20. doi: 10.1186/s10194-016-0612-2. Epub 2016 Mar 8.Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology. 2006;67(1):109-13 doi: 10.1007/s11916-008-0023-4Paemeleire K, Bahra A, Evers S, et al. Medication-overuse headache in patients with cluster headache. Neurology. 2006;67(1):109-13 doi: 10.1007/s11916-008-0023-4Robbins MS, Grosberg BM, Napchan U, et al. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010 Apr 27;74(17):1358-64. doi: 10.1212/WNL.0b013e3181dad5deRobbins MS, Grosberg BM, Napchan U, et al. Clinical and prognostic subforms of new daily-persistent headache. Neurology. 2010 Apr 27;74(17):1358-64. doi: 10.1212/WNL.0b013e3181dad5deBaandrup L, Jensen R. Chronic post-traumatic headache – a clinical analysis in relation to the International Headache Classification. Cephalalgia. 2005 Feb;25(2):132-8. doi: 10.1111/j.1468-2982.2004.00818.xBaandrup L, Jensen R. Chronic post-traumatic headache – a clinical analysis in relation to the International Headache Classification. Cephalalgia. 2005 Feb;25(2):132-8. doi: 10.1111/j.1468-2982.2004.00818.xRussell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012 Jun;25(3):290-5. doi: 10.1097/WCO.0b013e328352c431Russell MB, Lundqvist C. Prevention and management of medication overuse headache. Curr Opin Neurol. 2012 Jun;25(3):290-5. doi: 10.1097/WCO.0b013e328352c431Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.Linde M, Gustavsson A, Stovner LJ, et al. The cost of headache disorders in Europe: the Eurolight project. Eur J Neurol. 2012 May;19(5):703-11. doi: 10.1111/j.1468-1331.2011.03612.x. Epub 2011 Dec 5.Bendtsen L, Munksgaard S, Tassorelli C, et al; COMOESTAS Consortium. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014 May;34(6):426-33. doi: 10.1177/0333102413515338. Epub 2013 Dec 9.Bendtsen L, Munksgaard S, Tassorelli C, et al; COMOESTAS Consortium. Disability, anxiety and depression associated with medication-overuse headache can be considerably reduced by detoxification and prophylactic treatment. Results from a multicentre, multinational study (COMOESTAS project). Cephalalgia. 2014 May;34(6):426-33. doi: 10.1177/0333102413515338. Epub 2013 Dec 9.Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al; MOTS Investigators. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021 Feb;61(2):351-62. doi: 10.1111/head.14056. Epub 2021 Jan 12.Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al; MOTS Investigators. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial. Headache. 2021 Feb;61(2):351-62. doi: 10.1111/head.14056. Epub 2021 Jan 12.Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden Results From the CaMEO Study. Neurol Clin Pract. 2021 Jun;11(3):216-26. doi: 10.1212/CPJ.0000000000001037Schwedt TJ, Buse DC, Argoff CE, et al. Medication Overuse and Headache Burden Results From the CaMEO Study. Neurol Clin Pract. 2021 Jun;11(3):216-26. doi: 10.1212/CPJ.0000000000001037Tassorelli C, Jensen R, Allena M, et al. The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study. Cephalalgia. 2017 Oct;37(12):1115-25. doi: 10.1177/0333102416660549. Epub 2016 Jul 20.Tassorelli C, Jensen R, Allena M, et al. The added value of an electronic monitoring and alerting system in the management of medication-overuse headache: A controlled multicentre study. Cephalalgia. 2017 Oct;37(12):1115-25. doi: 10.1177/0333102416660549. Epub 2016 Jul 20.Katsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol. 2007 Jun;20(3):326-30. doi: 10.1097/WCO.0b013e328136c21cKatsarava Z, Jensen R. Medication-overuse headache: where are we now? Curr Opin Neurol. 2007 Jun;20(3):326-30. doi: 10.1097/WCO.0b013e328136c21cDiener HC, Antonaci F, Braschinsky M, et al. European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol. 2020 Jul;27(7):1102- 16. doi: 10.1111/ene.14268. Epub 2020 May 19.Diener HC, Antonaci F, Braschinsky M, et al. European Academy of Neurology guideline on the management of medication-overuse headache. Eur J Neurol. 2020 Jul;27(7):1102- 16. doi: 10.1111/ene.14268. Epub 2020 May 19.Сергеев АВ, Мещерина МИ, Табеева ГР. Головная боль, связанная с избыточным приемом анальгетиков: клинико-психологический и нейрофизиологический анализ, особенности периода отмены. Эпилепсия и пароксизмальные состояния. 2011;3(3):21-8.Sergeyev AV, Meshcherina MI, Tabeyeva GR. Headache associated with excessive usage of analgesics: clinical-psychological and neurophysiological analysis, and specifics of the period of the period of drug withdrawal. Epilepsiya i paroksizmal'nyye sostoyaniya. 2011;3(3):21-8 (In Russ.).Истомина ОИ, Филатова ЕГ. Абузусная головная боль: социально-демографический и клинический анализ. Врач. 2011;(1):68-71.Istomina OI, Filatova EG. Medication overuse headache: sociodemographic and clinical analyses. Vrach. 2011;(1):68-71 (In Russ.)Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014 Aug;34(9):645-55. doi: 10.1177/0333102414521508. Epub 2014 Feb 20.Tassorelli C, Jensen R, Allena M, et al. A consensus protocol for the management of medication-overuse headache: Evaluation in a multicentric, multinational study. Cephalalgia. 2014 Aug;34(9):645-55. doi: 10.1177/0333102414521508. Epub 2014 Feb 20.Kristoffersen ES, Lundqvist C. Medicationoveruse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014 Apr;5(2):87-99. doi: 10.1177/2042098614522683Kristoffersen ES, Lundqvist C. Medicationoveruse headache: epidemiology, diagnosis and treatment. Ther Adv Drug Saf. 2014 Apr;5(2):87-99. doi: 10.1177/2042098614522683Osipova V, Jensen R, Tassorelli C. The use of diaries in the management of headache. In: Martelletti P, Steiner TJ, editors. Handbook of Headache (Practical Management). 2011. Vol. 4. P. 197-209. doi: 10.1007/978-88-470-1700-9_13Osipova V, Jensen R, Tassorelli C. The use of diaries in the management of headache. In: Martelletti P, Steiner TJ, editors. Handbook of Headache (Practical Management). 2011. Vol. 4. P. 197-209. doi: 10.1007/978-88-470-1700-9_13Mitsikostas DD, Ashina M, Craven A, et al & EHF Committee. European Headache Federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5. doi: 10.1186/s10194-016-0596- y. Epub 2016 Feb 9.Mitsikostas DD, Ashina M, Craven A, et al & EHF Committee. European Headache Federation consensus on technical investigation for primary headache disorders. J Headache Pain. 2015;17:5. doi: 10.1186/s10194-016-0596- y. Epub 2016 Feb 9.Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994 Jul;44(7):1353-4. doi: 10.1212/wnl.44.7.1353Practice parameter: the utility of neuroimaging in the evaluation of headache in patients with normal neurologic examinations (summary statement). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 1994 Jul;44(7):1353-4. doi: 10.1212/wnl.44.7.1353Осипова ВВ, Скоробогатых КВ, Артеменко АР, Сергеев АВ. Тяжелая лекарственно-индуцированная головная боль с возможными повторными ее статусами у пациента с хронической головной болью напряжения. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):73-8. doi: 10.14412/2074-2711-2020-4-73-78.Osipova VV, Skorobogatykh KV, Artemenko AR, Sergeev AV. Severe druginduced headache with its possible recurrent statuses in a patient with chronic tension headache. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):73-8. doi: 10.14412/2074-2711-2020-4-73-78 (In Russ.).Филатова ЕГ, Осипова ВВ, Табеева ГР и др. Диагностика и лечение мигрени: рекомендации российских экспертов. Неврология, нейропсихиатрия, психосоматика. 2020;12(4):4-14. doi: 10.14412/2074-2711- 2020-4-4-14.Filatova EG, Osipova VV, Tabeeva GR, et al. Diagnosis and treatment of migraine: Russian experts' recommendations. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020;12(4):4- 14. doi: 10.14412/2074-2711-2020-4-4-14 (In Russ.).Schwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-zSchwedt TJ, Alam A, Reed ML, et al. Factors associated with acute medication overuse in people with migraine: results from the 2017 migraine in America symptoms and treatment (MAST) study. J Headache Pain. 2018 May 24;19(1):38. doi: 10.1186/s10194-018-0865-zCevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi: 10.1111/j.1526-4610.2008.01257.xCevoli S, Sancisi E, Grimaldi D, et al. Family history for chronic headache and drug overuse as a risk factor for headache chronification. Headache. 2009 Mar;49(3):412-8. doi: 10.1111/j.1526-4610.2008.01257.xBigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 Jun;24(6):483-90. doi: 10.1111/j.1468-2982.2004.00691.xBigal ME, Rapoport AM, Sheftell FD, et al. Transformed migraine and medication overuse in a tertiary headache centre-clinical characteristics and treatment outcomes. Cephalalgia. 2004 Jun;24(6):483-90. doi: 10.1111/j.1468-2982.2004.00691.xMeng ID, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia. 2011 May;31(7):851-60. doi: 10.1177/0333102411402367. Epub 2011 Mar 28.Meng ID, Dodick D, Ossipov MH, Porreca F. Pathophysiology of medication overuse headache: insights and hypotheses from preclinical studies. Cephalalgia. 2011 May;31(7):851-60. doi: 10.1177/0333102411402367. Epub 2011 Mar 28.Calabresi P, Cupini L. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005 Feb;26(2):62-8. doi: 10.1016/j.tips.2004.12.008Calabresi P, Cupini L. Medication-overuse headache: similarities with drug addiction. Trends Pharmacol Sci. 2005 Feb;26(2):62-8. doi: 10.1016/j.tips.2004.12.008Srikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesicinduced headache. Cephalalgia. 1996 Oct;16(6):419-22. doi: 10.1046/j.1468-2982.1996.1606419.xSrikiatkhachorn A, Anthony M. Serotonin receptor adaptation in patients with analgesicinduced headache. Cephalalgia. 1996 Oct;16(6):419-22. doi: 10.1046/j.1468-2982.1996.1606419.xKondratieva N, Azimova J, Skorobogatykh K, et al. Biomarkers of migraine: Part 1 – Genetic markers. J Neurol Sci. 2016 Oct 15;369:63-76. doi: 10.1016/j.jns.2016.08.008. Epub 2016 Aug 3.Kondratieva N, Azimova J, Skorobogatykh K, et al. Biomarkers of migraine: Part 1 – Genetic markers. J Neurol Sci. 2016 Oct 15;369:63-76. doi: 10.1016/j.jns.2016.08.008. Epub 2016 Aug 3.Bongsebandhu-Phubhakdi S, Srikiatkhachorn A. Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep. 2012 Feb;16(1):110-5. doi: 10.1007/s11916-011- 0234-yBongsebandhu-Phubhakdi S, Srikiatkhachorn A. Pathophysiology of medication-overuse headache: implications from animal studies. Curr Pain Headache Rep. 2012 Feb;16(1):110-5. doi: 10.1007/s11916-011- 0234-yMunksgaard S, Ertsey C, Frandsen E, et al. Circulating nociceptin and CGRP in medication-overuse headache. Acta Neurol Scand. 2019 Mar;139(3):269-75. doi: 10.1111/ane.13053. Epub 2018 Dec 11.Munksgaard S, Ertsey C, Frandsen E, et al. Circulating nociceptin and CGRP in medication-overuse headache. Acta Neurol Scand. 2019 Mar;139(3):269-75. doi: 10.1111/ane.13053. Epub 2018 Dec 11.Riederer F, Schaer M, Gantenbein AR, et al. Cortical Alterations in MedicationOveruse Headache. Headache. 2017 Feb;57(2):255-65. doi: 10.1111/head.12993. Epub 2016 Dec 28.Riederer F, Schaer M, Gantenbein AR, et al. Cortical Alterations in MedicationOveruse Headache. Headache. 2017 Feb;57(2):255-65. doi: 10.1111/head.12993. Epub 2016 Dec 28.Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4.Diener HC, Dodick D, Evers S, et al. Pathophysiology, prevention, and treatment of medication overuse headache. Lancet Neurol. 2019 Sep;18(9):891-902. doi: 10.1016/S1474-4422(19)30146-2. Epub 2019 Jun 4.Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018 Jun;38(7):1316-25. doi: 10.1177/0333102417736898. Epub 2017 Oct 10.Carlsen LN, Westergaard ML, Bisgaard M, et al. National awareness campaign to prevent medication-overuse headache in Denmark. Cephalalgia. 2018 Jun;38(7):1316-25. doi: 10.1177/0333102417736898. Epub 2017 Oct 10.Шагбазян АЭ, Ковальчук НА, Табеева ГР. Роль образовательных программ в ведении пациентов с медикаментозно-индуцированной головной болью. Неврология, нейропсихиатрия, психосоматика. 2021;13(3):27-33. doi: 10.14412/2074-2711-2021-3-27-33.Shagbazyan AE, Kovalchuk NA, Tabeeva GR. Role of educational programs in management of patients with medicationoveruse headache. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021;13(3):27-33. doi: 10.14412/2074-2711-2021-3-27-33 (In Russ.).Данилов АБ, Шевченко ЕВ. Влияние информационно-образовательной подготовки пациента на клинические, финансово-экономические факторы и удовлетворенность лечением. Неврология, нейропсихиатрия, психосоматика. 2014;(2):29-33. doi: 10.14412/2074-2711-2014-2-29-33.Danilov AB, Shevchenko EV. Impact of patient information-educational preparation on clinical, financial, and economic factors and treatment satisfaction. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014;(2):29- 33. doi: 10.14412/2074-2711-2014-2-29-33 (In Russ.).Kristoffersen ES, Straand J, Russell MB, Lundqvist C. Lasting improvement of medication-overuse headache after brief intervention – a long-term follow-up in primary care. Eur J Neurol. 2017 Jul;24(7):883-91. doi: 10.1111/ene.13318. Epub 2017 May 23.Kristoffersen ES, Straand J, Russell MB, Lundqvist C. Lasting improvement of medication-overuse headache after brief intervention – a long-term follow-up in primary care. Eur J Neurol. 2017 Jul;24(7):883-91. doi: 10.1111/ene.13318. Epub 2017 May 23.Zeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006 Oct;26(10):1192-8. doi: 10.1111/j.1468-2982.2006.01190.xZeeberg P, Olesen J, Jensen R. Discontinuation of medication overuse in headache patients: recovery of therapeutic responsiveness. Cephalalgia. 2006 Oct;26(10):1192-8. doi: 10.1111/j.1468-2982.2006.01190.xCarlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 2018;38:225-36. doi: 10.1177/0333102417737779Carlsen LN, Munksgaard SB, Jensen RH, Bendtsen L. Complete detoxification is the most effective treatment of medication-overuse headache: a randomized controlled open-label trial. Cephalalgia 2018;38:225-36. doi: 10.1177/0333102417737779Tepper SJ, Diener HC, Ashina M, et al. Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology. 2019 May 14;92(20):e2309- e2320. doi: 10.1212/WNL.0000000000007497Tepper SJ, Diener HC, Ashina M, et al. Erenumab in chronic migraine with medication overuse: Subgroup analysis of a randomized trial. Neurology. 2019 May 14;92(20):e2309- e2320. doi: 10.1212/WNL.0000000000007497De Goffau MJ, Klaver ARE, Willemsen MG, et al. The Effectiveness of Treatments for Patients with Medication Overuse Headache: A Systematic Review and Meta-Analysis. J Pain. 2017 Jun;18(6):615- 27. doi: 10.1016/j.jpain.2016.12.005De Goffau MJ, Klaver ARE, Willemsen MG, et al. The Effectiveness of Treatments for Patients with Medication Overuse Headache: A Systematic Review and Meta-Analysis. J Pain. 2017 Jun;18(6):615- 27. doi: 10.1016/j.jpain.2016.12.005Сергеев АВ, Парфенов ВА. Лекарственно-индуцированная головная боль. Практические рекомендации. Медицинский совет. 2018;(1):26-32. doi: 10.21518/2079-701X2018-1-26-32.Sergeev AV, Parfenov VA. Medication overuse headache: Practical guidelines. Meditsinskiy sovet = Medical Council. 2018;(1):26-32. doi: 10.21518/2079-701X-2018-1-26-32 (In Russ.)].Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2016 Apr;36(4):371-86. doi: 10.1177/0333102415593088. Epub 2015 Jun 29.Chiang CC, Schwedt TJ, Wang SJ, Dodick DW. Treatment of medication-overuse headache: a systematic review. Cephalalgia. 2016 Apr;36(4):371-86. doi: 10.1177/0333102415593088. Epub 2015 Jun 29.Rossi P, Di Lorenzo C, Faroni J. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26(9):1097-105. doi: 10.1111/j.1468-2982.2006.01175.xRossi P, Di Lorenzo C, Faroni J. Advice alone vs. structured detoxification programmes for medication overuse headache: a prospective, randomized trial in transformed migraine patients with low medical needs. Cephalalgia. 2006;26(9):1097-105. doi: 10.1111/j.1468-2982.2006.01175.xToom K, Braschinsky M, Obermann M, Katsarava Z. Secondary headache attributed to exposure to or overuse of a substance. Cephalalgia. 2021 Apr;41(4):443-52. doi: 10.1177/0333102420942238Toom K, Braschinsky M, Obermann M, Katsarava Z. Secondary headache attributed to exposure to or overuse of a substance. Cephalalgia. 2021 Apr;41(4):443-52. doi: 10.1177/0333102420942238Silberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 Feb;47(2):170-80. doi: 10.1111/j.1526-4610.2006.00684.xSilberstein SD, Lipton RB, Dodick DW, et al. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial. Headache. 2007 Feb;47(2):170-80. doi: 10.1111/j.1526-4610.2006.00684.xNegro A, Curto M, Lionetto L, Martelletti P. A two years open-label prospective study of OnabotulinumtoxinA. 195 U in medication overuse headache: a real-world experience. J Headache Pain. 2015;17:1. doi: 10.1186/s10194-016-0591-3. Epub 2016 Jan 21.Negro A, Curto M, Lionetto L, Martelletti P. A two years open-label prospective study of OnabotulinumtoxinA. 195 U in medication overuse headache: a real-world experience. J Headache Pain. 2015;17:1. doi: 10.1186/s10194-016-0591-3. Epub 2016 Jan 21.Pazdera L, Ning X, Campos VR, et al. Efficacy of fremanezumab in patients with migraine and documented inadequate response to 3 or 4 migraine preventive medication classes and medication overuse in the international, multicenter, randomized placebo-controlled FOCUS study. Poster, 14th European Headache Federation Congress, 2020. doi: 10.1186/s10194-021-01232-8Pazdera L, Ning X, Campos VR, et al. Efficacy of fremanezumab in patients with migraine and documented inadequate response to 3 or 4 migraine preventive medication classes and medication overuse in the international, multicenter, randomized placebo-controlled FOCUS study. Poster, 14th European Headache Federation Congress, 2020. doi: 10.1186/s10194-021-01232-8Raggi A, Giovannetti AM, Leonardi M, et al. Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study. Headache. 2017 Jan;57(1):60-70. doi: 10.1111/head.12979Raggi A, Giovannetti AM, Leonardi M, et al. Predictors of 12-Months Relapse After Withdrawal Treatment in Hospitalized Patients With Chronic Migraine Associated With Medication Overuse: A Longitudinal Observational Study. Headache. 2017 Jan;57(1):60-70. doi: 10.1111/head.12979Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z, et al. Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study. Cephalalgia. 2018 Feb;38(2):265-73. doi: 10.1177/0333102416683918Zidverc-Trajkovic JJ, Pekmezovic T, Jovanovic Z, et al. Long-term predictors of remission in patients treated for medication-overuse headache at a specialized headache center: A prospective cohort study. Cephalalgia. 2018 Feb;38(2):265-73. doi: 10.1177/0333102416683918

The authors declare that there are no conflicts of interest present.